Printer Friendly

Baxter to split into two businesses.

DEERFIELD, Ill. -- Baxter International Inc. has announced plans to create two separate, independent global health care companies, one focused on developing and marketing biopharmaceuticals and the other focused on medical products.

The company notes that it has positioned both businesses to be successful, profitable and sustainable independent companies, a decision that reflects the evolution of multifaceted strategies that emphasize a commitment to innovation and operational excellence.

"Baxter has an established history of executing successful spin-offs, and we have continued to evaluate the separation of these two businesses in response to diverging business dynamics and the rapidly changing macro-environment," comments chairman and chief executive officer Robert Parkinson Jr.

COPYRIGHT 2014 Racher Press, Inc.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2014 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:RX/News
Publication:Chain Drug Review
Date:Apr 28, 2014
Previous Article:Rx patients want more digital outreach.
Next Article:Challenges for ACOs mean opportunities for pharmacies.

Terms of use | Privacy policy | Copyright © 2019 Farlex, Inc. | Feedback | For webmasters